Outcomes of AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Following Treatment with Venetoclax and Hypomethylating Agents
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI